circ_DENND1B inhibited ccRCC cell progression by promoting TIMP2 expression by sponging miR-122-5p, suggesting that circ_DENND1B might be an effective therapeutic target for ccRCC. The gene discussed is TIMP2; the disease is nonpapillary renal cell carcinoma.